Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: A nationwide population-based cohort study

The Lancet HIV

Volumn 2, Issue 7, 2015, Pages e288-e298

  Rasmussen, Line D ^a   May, Margaret T ^b   Kronborg, Gitte ^c   Larsen, Carsten S ^d   Pedersen, Court ^a   Gerstoft, Jan ^e   Obel, Niels ^e  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c Mental Health Services CPH   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGING; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CHRONIC LIVER DISEASE; COGNITIVE DEFECT; COHORT ANALYSIS; DENMARK; FEMALE; FOLLOW UP; FRAGILITY FRACTURE; FUNDING; HEART INFARCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OUTCOME ASSESSMENT; POPULATION DYNAMICS; PRIORITY JOURNAL; RISK FACTOR; CARDIOVASCULAR DISEASES; COMORBIDITY; HEALTH SURVEY; HIV INFECTIONS; LIVER DISEASES; NEOPLASMS; NEUROCOGNITIVE DISORDERS; OSTEOPOROTIC FRACTURES; REGRESSION ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; VIROLOGY;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGING; ANTI-HIV AGENTS; CARDIOVASCULAR DISEASES; COHORT STUDIES; COMORBIDITY; DENMARK; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; LIVER DISEASES; MALE; NEOPLASMS; NEUROCOGNITIVE DISORDERS; OSTEOPOROTIC FRACTURES; POPULATION SURVEILLANCE; REGRESSION ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84947028889     PISSN: None     EISSN: 23523018     Source Type: Journal    
DOI: 10.1016/S2352-3018(15)00077-6     Document Type: Article

References (30)

1. Obel N, Thomsen HF, Kronborg G, et al. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis 2007; 44: 1625-31.
2. Rasmussen LD, Engsig FN, Christensen H, et al. Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study. AIDS 2011; 25: 1637-46.
3. Helleberg M, Gerstoft J, Afzal S, et al. Risk of cancer among HIV-infected individuals compared to the background population: impact of smoking and HIV. AIDS 2014; 28: 1499-508.
4. Lescure FX, Omland LH, Engsig FN, et al. Incidence and impact on mortality of severe neurocognitive disorders in persons with and without HIV infection: a Danish nationwide cohort study. Clin Infect Dis 2011; 52: 235-43.
5. Rasch MG, Helleberg M, Feldt-Rasmussen B, et al. Increased risk of dialysis and end-stage renal disease among HIV patients in Denmark compared with the background population. Nephrol Dial Transplant 2014; 29: 1232-38.
6. Weber R, Sabin CA, Friis-Moller N, et al. Liver-related deaths in persons infected with the human immunodefi ciency virus: the D:A:D study. Arch Intern Med 2006; 166: 1632-41.
7. Hansen AB, Gerstoft J, Kronborg G, et al. Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study. AIDS 2012; 26: 285-93.
8. Deeks SG. HIV infection, infl ammation, immunosenescence, and aging. Annu Rev Med 2011; 62: 141-55.
9. Omland LH, Ahlstrom MG, Obel N. Cohort profi le update: the Danish HIV Cohort Study (DHCS). Int J Epidemiol 2014; 43: 1769-69e.
10. Bruggmann P, Berg T, Ovrehus AL, et al. Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat 2014; 21 (suppl 1): 5-33.
11. Neuhaus J, Jacobs DR Jr, Baker JV, et al. Markers of infl ammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 2010; 201: 1788-95.
12. Duprez DA, Neuhaus J, Kuller LH, et al. Infl ammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS One 2012; 7: e44454.
13. Smith CJ, Ryom L, Weber R, et al, for the D:A:D Study Group. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet 2014; 384: 241-48.
14. Phillips AN, Carr A, Neuhaus J, et al. Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial. Antivir Ther 2008; 13: 177-87.
15. Klein DL, Leyden WA; Chao CR, et al. No diff erence in incidence of myocardial infarction for HIV+ and HIV-individuals in recent years. Conference on Retroviruses and Opportunistic Infections; Boston, MA, USA; March 3-6, 2014.
16. Klein DB, Leyden WA, Xu L, et al. Declining relative risk for myocardial infarction among HIV-positive compared with HIV-negative individuals with access to care. Clin Infect Dis 2015; 60: 1278-80.
17. Shirley DK, Kaner RJ, Glesby MJ. Eff ects of smoking on non-AIDS-related morbidity in HIV-infected patients. Clin Infect Dis 2013; 57: 275-82.
18. Helleberg M, Afzal S, Kronborg G, et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis 2013; 56: 727-34.
19. Rasmussen LD, Helleberg M, May M, et al. Myocardial infarction among Danish HIV-infected individuals: population attributable fractions associated with smoking. Clin Infect Dis 2015; 60: 1415-23.
20. Ingle SM, May MT, Gill MJ, et al. Impact of risk factors for specifi c causes of death in the fi rst and subsequent years of antiretroviral therapy among HIV-infected patients. Clin Infect Dis 2014; 59: 287-97.
21. Worm SW, Bower M, Reiss P, et al. Non-AIDS defi ning cancers in the D:A:D Study-time trends and predictors of survival: a cohort study. BMC Infect Dis 2013; 13: 471.
22. Bhaskaran K, Mussini C, Antinori A, et al. Changes in the incidence and predictors of human immunodefi ciency virus-associated dementia in the era of highly active antiretroviral therapy. Ann Neurol 2008; 63: 213-21.
23. Abraham AG, Althoff KN, Jing Y, et al. End stage renal disease among HIV-Infected adults in North America. Clin Infect Dis 2014; 60: 941-49.
24. Danish Nephrology Registry. Annual Report 2013. http://www. nephrology.dk/Publikationer/Landsregister/%C3%85rsrapport%20 2013.pdf (accessed Jan 7, 2015).
25. Kovari H, Ledergerber B, Battegay M, et al. Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis B or C virus co-infection. Clin Infect Dis 2010; 50: 502-11.
26. Bruera D, Luna N, David DO, Bergoglio LM, Zamudio J. Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS 2003; 17: 1917-23.
27. Hansen AB, Obel N, Nielsen H, Pedersen C, Gerstoft J. Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial. HIV Med 2011; 12: 157-65.
28. Bonjoch A, Figueras M, Estany C, et al. High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study. AIDS 2010; 24: 2827-33.
29. Ofotokun I, McIntosh E, Weitzmann MN. HIV: infl ammation and bone. Curr HIV/AIDS Rep 2012; 9: 16-25.
30. Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sorensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol 2011; 11: 83.